
Corporate venture capital can pay, but only if you get the structure right
Jun 09, 2016 09:25 am UTC| Insights & Views Business
Large established firms increasingly rely on external sources for innovation. One way these firms are seeking to foster innovative activity is via corporate venture capital programs. According to the National Venture...
ADVA Optical Networking Joins Consortium to Create Revolutionary Data Center Technology
Jun 09, 2016 07:15 am UTC| Business
DRESDEN, Germany, June 9, 2016 -- ADVA Optical Networking announced today that it is playing a key role in the Directly Modulated Lasers on Silicon (DIMENSION) project. DIMENSION, which brings together a consortium of...
OCEARCH Launches Kickstarter Campaign to Fund White Shark Expedition in New York
Jun 09, 2016 06:10 am UTC| Business
PARK CITY, Utah, June 9, 2016 -- For the first time, OCEARCH is inviting the public to take part in funding a shark tagging research expedition in Long Island, NY this upcoming summer. The non-profit organization, which...
Jun 09, 2016 06:07 am UTC| Business
OSLO, Norway, June 9, 2016 -- Targovax receives regulatory approval to conduct a study in Spain to assess its ONCOS-102 product in combination with chemotherapy in patients with malignant pleural mesothelioma (MPM), a...
Aris Bogdaneris to speak at Goldman Sachs European Financials Conference in Paris
Jun 09, 2016 06:05 am UTC| Business
AMSTERDAM, Netherlands, June 9, 2016 -- Today, 9 June 2016, Aris Bogdaneris, Head of Challengers Growth Markets and Member of the Management Board of ING Bank, will be presenting at the Goldman Sachs European Financials...
Galapagos selected for AEX Index
Jun 09, 2016 05:35 am UTC| Business
MECHELEN, Belgium, June 9, 2016 -- Galapagos NV (Euronext NASDAQ: GLPG) announces that Euronext has selected Galapagos NV for inclusion in the AEX1Index on Euronext Amsterdam, effective 20 June 2016. Galapagos is the...
Jun 09, 2016 05:24 am UTC| Business
Clinical data reported from completed phase 1/2a study of BAL101553, with once-weekly 2-hour infusion showing signals of clinical activity Design of ongoing phase 1/2a study with once-daily oral BAL101553 presented,...